All Stories

  1. SGLT2 Inhibitors vs Other Glucose-Lowering Drugs: Kidney Outcomes in Real-World Clinical Practice

    Article • Diabetes Care, October 2021, American Diabetes Association

    Yuichiro Yano, Jun Wada